Literature DB >> 141322

Rationale for adjuvant chemotherapy.

F M Schabel.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 141322     DOI: 10.1002/1097-0142(197706)39:6<2875::aid-cncr2820390675>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  11 in total

1.  Portable filter-based microdevice for detection and characterization of circulating tumor cells.

Authors:  Henry K Lin; Siyang Zheng; Anthony J Williams; Marija Balic; Susan Groshen; Howard I Scher; Martin Fleisher; Walter Stadler; Ram H Datar; Yu-Chong Tai; Richard J Cote
Journal:  Clin Cancer Res       Date:  2010-09-28       Impact factor: 12.531

2.  New strategies in cancer chemotherapy.

Authors:  G Bonadonna
Journal:  Cell Biophys       Date:  1986-12

Review 3.  Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited?

Authors:  J H Kearsley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

4.  Adjuvant chemotherapy for operable breast cancer with positive axillary nodes: a comparison of CMFVP versus L-PAM.

Authors:  S E Rivkin; H Glucksberg; M Foulkes; C K Osborne; W Tranum; N Gad-el-Mawla; J Constanzi
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

Review 5.  Circulating tumor cells: from bench to bedside.

Authors:  Marija Balic; Anthony Williams; Henry Lin; Ram Datar; Richard J Cote
Journal:  Annu Rev Med       Date:  2012-10-18       Impact factor: 13.739

6.  Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.

Authors:  G Bonadonna; P Valagussa; A Rossi; G Tancini; C Brambilla; M Zambetti; U Veronesi
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

7.  Detection of occult bone marrow micrometastases in patients with operable lung carcinoma.

Authors:  R J Cote; E J Beattie; B Chaiwun; S R Shi; J Harvey; S C Chen; A E Sherrod; S Groshen; C R Taylor
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

8.  Sequential assays of hormone receptors and the Tritiated Thymidine Labeling Index in 7,12-dimethylbenz(a)anthracene-induced rat mammary cancers.

Authors:  K Araki; M Kimura; K Sakamoto; R Nishimura; J Yamashita; M Akagi
Journal:  Jpn J Surg       Date:  1985-03

9.  Multimodal treatment in operable breast cancer: five-year results of the CMF programme.

Authors:  A Rossi; G Bonadonna; P Valagussa; U Veronesi
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

10.  Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.

Authors:  William Weidong Du; Burton B Yang; Bing L Yang; Zhaoqun Deng; Ling Fang; Sze Wan Shan; Zina Jeyapalan; Yaou Zhang; Arun Seth; Albert J Yee
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.